2) proton pump inhibitor
质子泵抑制剂
1.
Sequelae of hypergastrinemia due to long-term administration of proton pump inhibitors and its management;
长期使用质子泵抑制剂所致高胃泌素血症及其对策
2.
Prevention of acute pancreatitis induced by ERCP with the union between somatostatin and proton pump inhibitor;
生长抑素和质子泵抑制剂联合应用预防ERCP术后胰腺炎
3.
Effect of proton pump inhibitor combined with cisapride on difficultly treating bronchial asthma with gastroesophageal reflux disease;
质子泵抑制剂联用西沙必利在治疗难治性支气管哮喘并胃食管反流病中的作用
3) proton pump inhibitors
质子泵抑制剂
1.
Studies of proton pump inhibitors and tumor resistance to antitumor drugs;
质子泵抑制剂与肿瘤耐药研究
2.
Recent progresses of the proton pump inhibitors benzimidazoles;
苯并咪唑类质子泵抑制剂的药理和临床研究进展
3.
Role of Proton Pump Inhibitors in Non-steroidal Anti-inflammatory Drugs-associated Gastrointestinal Diseases:a Meta-analysis;
质子泵抑制剂对非甾体抗炎药相关胃肠疾病的疗效:荟萃分析
4) PPI
质子泵抑制剂
1.
New Generation Antiulcer Agents-Proton Pump Inhibitors (PPI);
新一代抗溃疡药——质子泵抑制剂
2.
Effect of PPI on anaylase release from isolated pancreatic acini.;
质子泵抑制剂对离体胰腺腺泡淀粉酶分泌的影响
3.
Imidazo[4 ,5-b]pyridine compounds are the hot issue in the research of PPI.
2-巯基-5-甲氧基咪唑并[4,5-b]吡啶是合成新型咪唑并[4,5-b]吡啶类质子泵抑制剂的关键中间体。
5) proton pump inhibitors(PPIs)
质子泵抑制剂(PPIs)
6) reversible inhibitor
可逆抑制剂
1.
The binding manner and inhibiting mechanism are introduced, with an emphasis on the mechanism and structure-activity relationship of both reversible and irreversible inhibitors.
综述了表皮生长因子受体酪氨酸激酶的ATP竞争性抑制剂的研究进展 ,介绍了抑制剂结合受体蛋白的方式及其作用机理 ,重点介绍了可逆抑制剂和不可逆抑制剂的作用机理及其构效关系 。
补充资料：质子泵抑制剂
分子式：
CAS号：
性质：又称质子泵阻滞剂。能选择性抑制胃黏膜壁细胞H+泵(H+，K+ -ATP酶)，抑制壁细胞分泌H+的终末步骤，减少胃酸分泌的药物，又称H+泵抑制剂。代表药物为奥美拉唑(omeprazole)。
CAS号：
性质：又称质子泵阻滞剂。能选择性抑制胃黏膜壁细胞H+泵(H+，K+ -ATP酶)，抑制壁细胞分泌H+的终末步骤，减少胃酸分泌的药物，又称H+泵抑制剂。代表药物为奥美拉唑(omeprazole)。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条